The introduction of certain drugs may lead consumers to focus on high protein meals to maintain muscle-to-fat ratios. Companies like Nestle view this as an opportunity to market suitable food products. On the contrary, companies like Coca Cola, PepsiCo, McDonald's, Kraft Foods, and General Foods, often seen as obesity indices, may face challenges as a significant portion of their customer base drives a majority of their sales, especially in the drinks industry. These processed food companies might struggle as drugs promoting weight loss become more prevalent, affecting their customer base and sales volume. The speaker advocates for consuming regular foods instead of processed ones, highlighting the challenges faced by the packaged food industry amidst evolving consumer preferences.
Kara and Scott discuss the Department of Justice's antitrust suit against Live Nation, News Corp's $250 million deal with OpenAI, and Nestle's new frozen food brand aimed at Ozempic users. Then, Scarlett Johansson alleges OpenAI copied her voice after she refused to license it to Sam Altman, though new reporting says a voice actress was hired months earlier. How does OpenAI move past these accusations, and regain trust? Plus, Nvidia shares blockbuster earnings, while Trump Media's numbers are lackluster. Finally, our Friend of Pivot is Julia Angwin, CEO and founder of Proof News, and a contributing opinion writer for the New York Times. Julia shares why she thinks AI hype is overblown, and why she opposes the TikTok ban.
Follow Julia at @juliaangwin
Follow us on Instagram and Threads at @pivotpodcastofficial.
Follow us on TikTok at @pivotpodcast.
Send us your questions by calling us at 855-51-PIVOT, or at nymag.com/pivot.
Learn more about your ad choices. Visit podcastchoices.com/adchoices